Bruker Corporation (BRKR) is a publicly traded Healthcare sector company. As of May 20, 2026, BRKR trades at $44.76 with a market cap of $6.51B and a P/E ratio of -182.83. BRKR moved +3.87% today. Year to date, BRKR is -13.64%; over the trailing twelve months it is +15.89%. Its 52-week range spans $28.53 to $72.94. Analyst consensus is buy with an average price target of $47.00. Rallies surfaces BRKR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading BRKR stock inside the company?
Recent BRKR insider activity includes Munch Mark sold 2.00K, Munch Mark sold 2.00K, Munch Mark sold 2.00K, Munch Mark sold 2.00K, and Munch Mark sold 7.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
BRKR Key Metrics
Key financial metrics for BRKR
Metric
Value
Price
$44.76
Market Cap
$6.51B
P/E Ratio
-182.83
EPS
$-0.24
Dividend Yield
0.05%
52-Week High
$72.94
52-Week Low
$28.53
Volume
1.62M
Avg Volume
0
Revenue (TTM)
$3.46B
Net Income
$-9.40M
Gross Margin
45.29%
Recent BRKR Insider Trades
Munch Mark sold 2.00K (~$79.80K) on Apr 15, 2026.
Munch Mark sold 2.00K (~$70.88K) on Mar 13, 2026.
Munch Mark sold 2.00K (~$73.88K) on Feb 13, 2026.
Munch Mark sold 2.00K (~$98.40K) on Jan 15, 2026.
Munch Mark sold 7.00K (~$385.00K) on Jan 12, 2026.
Recent BRKR insider activity includes Munch Mark sold 2.00K, Munch Mark sold 2.00K, Munch Mark sold 2.00K, Munch Mark sold 2.00K, and Munch Mark sold 7.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for BRKR?
Yes. Rallies tracks BRKR insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is BRKR research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BRKR. It does not provide personalized investment advice.
